A detailed history of Sector Gamma As transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sector Gamma As holds 63,348 shares of BMRN stock, worth $4.47 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
63,348
Previous 81,416 22.19%
Holding current value
$4.47 Million
Previous $7.11 Million 26.65%
% of portfolio
2.04%
Previous 2.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$74.43 - $92.22 $1.34 Million - $1.67 Million
-18,068 Reduced 22.19%
63,348 $5.22 Million
Q1 2024

May 08, 2024

SELL
$83.81 - $99.0 $404,886 - $478,269
-4,831 Reduced 5.6%
81,416 $7.11 Million
Q4 2023

Feb 05, 2024

SELL
$76.22 - $98.51 $747,032 - $965,496
-9,801 Reduced 10.2%
86,247 $8.32 Million
Q3 2023

Nov 06, 2023

SELL
$85.07 - $94.48 $5.67 Million - $6.29 Million
-66,620 Reduced 40.95%
96,048 $8.5 Million
Q2 2023

Aug 09, 2023

BUY
$86.68 - $100.3 $547,644 - $633,695
6,318 Added 4.04%
162,668 $14.1 Million
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $117,659 - $157,259
1,341 Added 0.87%
156,350 $15.2 Million
Q4 2022

Feb 07, 2023

BUY
$80.93 - $108.63 $3.67 Million - $4.93 Million
45,405 Added 41.43%
155,009 $16 Million
Q3 2022

Nov 09, 2022

BUY
$82.16 - $96.94 $356,985 - $421,204
4,345 Added 4.13%
109,604 $9.29 Million
Q2 2022

Aug 05, 2022

BUY
$71.48 - $86.85 $1.82 Million - $2.21 Million
25,500 Added 31.97%
105,259 $8.72 Million
Q1 2022

May 06, 2022

SELL
$74.28 - $92.69 $2.51 Million - $3.13 Million
-33,789 Reduced 29.76%
79,759 $6.15 Million
Q4 2021

Feb 08, 2022

BUY
$71.72 - $91.47 $8.14 Million - $10.4 Million
113,548 New
113,548 $10 Million
Q3 2021

Oct 29, 2021

SELL
$74.77 - $85.47 $5.16 Million - $5.89 Million
-68,964 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$75.51 - $84.79 $1.72 Million - $1.93 Million
-22,750 Reduced 24.81%
68,964 $5.75 Million
Q1 2021

May 10, 2021

BUY
$74.73 - $90.69 $6.85 Million - $8.32 Million
91,714 New
91,714 $6.93 Million
Q3 2020

Nov 09, 2020

SELL
$71.87 - $131.03 $7.8 Million - $14.2 Million
-108,482 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$79.55 - $124.22 $2.47 Million - $3.86 Million
-31,100 Reduced 22.28%
108,482 $13.4 Million
Q1 2020

May 11, 2020

BUY
$71.37 - $96.85 $4.62 Million - $6.26 Million
64,679 Added 86.35%
139,582 $11.8 Million
Q4 2019

Feb 12, 2020

BUY
$64.27 - $86.37 $4.81 Million - $6.47 Million
74,903 New
74,903 $6.33 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.